Dr. David Kershenobich Stalnikowitz, General Director of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán on the myriad issues surrounding diabetes in Mexico and how the Mexican healthcare system can evolve.
You have highlighted the importance of the institute operating as a reference center. What have been some of the new changes and research programs you implemented to maintain this positioning?
"Our research has generated key material to educate physicians, as well as patients."
